Puma Biotechnology Inc Stock Nyse
Equities
US74587V1070
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 231M | Sales 2025 * | 233M | Capitalization | 233M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 14M | EV / Sales 2024 * | 1.01 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1 x |
P/E ratio 2024 * |
18.7
x | P/E ratio 2025 * |
28.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.88% |
Latest transcript on Puma Biotechnology Inc
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+47.81% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |